Abstract
Highly active antiretroviral therapy [HAART] has increased the mean survival time in the AIDS stage by up to more than 10 years. Five different groups of antiretroviral medications are known, of which integrase and entry inhibitors represent the latest and most modern substances. The long survival time in the AIDS stage means that side effects and interactions become of greater relevance and have to be differentiated from the symptoms of Neuro-AIDS as such. Side effects of HAART tend to affect the central and peripheral nervous system as well as the muscles. Neurotoxicity of HAART components varies considerably and depends on the substance involved. They are to be considered with the choice of HAART as a treatment, and a corresponding combination of medication must be carefully discussed by the doctor and patient in those cases in which side effects on the nervous system by antiretroviral agents are already present. There are special cases, however, in which the associated side-effects are to be accepted and endured if no other combination of medications is possible-e.g. as a result of resistance development. Knowledge of HAART side effects and interactions with antiepileptics, antidepressants and analgetics are essential for the treatment of patients with Neuro-AIDS.
Keywords: HAART, neurotoxicity, central and peripheral nervous system, interactions
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Neurotoxicity and Side-Effects of Highly Active Antiretroviral Therapy [HAART] on the Central and Peripheral Nerve System
Volume: 8 Issue: 2
Author(s): I. W. Husstedt, D. Reichelt, E. Neuen-Jakob, F. Kastner, R. von Einsiedel, B. Vielhaber, G. Arendt, S. Evers and K. Hahn
Affiliation:
Keywords: HAART, neurotoxicity, central and peripheral nervous system, interactions
Abstract: Highly active antiretroviral therapy [HAART] has increased the mean survival time in the AIDS stage by up to more than 10 years. Five different groups of antiretroviral medications are known, of which integrase and entry inhibitors represent the latest and most modern substances. The long survival time in the AIDS stage means that side effects and interactions become of greater relevance and have to be differentiated from the symptoms of Neuro-AIDS as such. Side effects of HAART tend to affect the central and peripheral nervous system as well as the muscles. Neurotoxicity of HAART components varies considerably and depends on the substance involved. They are to be considered with the choice of HAART as a treatment, and a corresponding combination of medication must be carefully discussed by the doctor and patient in those cases in which side effects on the nervous system by antiretroviral agents are already present. There are special cases, however, in which the associated side-effects are to be accepted and endured if no other combination of medications is possible-e.g. as a result of resistance development. Knowledge of HAART side effects and interactions with antiepileptics, antidepressants and analgetics are essential for the treatment of patients with Neuro-AIDS.
Export Options
About this article
Cite this article as:
Husstedt W. I., Reichelt D., Neuen-Jakob E., Kastner F., Einsiedel von R., Vielhaber B., Arendt G., Evers S. and Hahn K., Neurotoxicity and Side-Effects of Highly Active Antiretroviral Therapy [HAART] on the Central and Peripheral Nerve System, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2009; 8 (2) . https://dx.doi.org/10.2174/187152309789152039
DOI https://dx.doi.org/10.2174/187152309789152039 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery Recent Advances in Nanoneurology for Drug Delivery to the Brain
Current Nanoscience Patent Selections:
Recent Patents and Topics on Imaging (Discontinued) Polymer-Based Drug Delivery Devices for Neurological Disorders
CNS & Neurological Disorders - Drug Targets 3D-QSAR and Docking Simulation Studies of Some Benzopyrone Derivatives as Inhibitors for Breast Cancer Stem Cell Growth via PGlycoprotein Mediated Efflux
Current Bioinformatics Herbal Medicine for Anxiety, Depression and Insomnia
Current Neuropharmacology The Effects of Soluble Aβ Oligomers on Neurodegeneration in Alzheimer's Disease
Current Pharmaceutical Design “Micromanaging” Glioblastoma Multiforme: The Potential of MicroRNAs, Circular RNAs, and the Hippo Pathway as Novel Treatment Strategies
Current Neurovascular Research Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain
Current Neuropharmacology Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Pyridoxal 5-Phosphate Enzymes as Targets for Therapeutic Agents
Current Medicinal Chemistry Synthesis and Evaluation of In Vivo Anticonvulsant Activity of 2,5- Disubstituted-1,3,4-Oxadiazole Derivatives
Letters in Drug Design & Discovery ERRATUM 1
Current Neuropharmacology Chemo-botanical and Neurological Accounts of Some Ayurvedic Plants Useful in Mental Health
The Natural Products Journal Classical Neurotransmitters and Neuropeptides Involved in Major Depression in a Multi-neurotransmitter System: A Focus on Antidepressant Drugs
Current Medicinal Chemistry Models in Research of Pharmacoresistant Epilepsy: Present and Future in Development of Antiepileptic Drugs
Current Medicinal Chemistry Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction
CNS & Neurological Disorders - Drug Targets Interleukin-4-Induced Oxidative Stress Via Microglial NADPH Oxidase Contributes to the Death of Hippocampal Neurons In Vivo
Current Aging Science Gut Microbiota as a Link between Modern Lifestyle and Alzheimer’s Disease
Current Aging Science Pharmacotherapy for SARS-CoV-2 and Seizures for Drug Repurposing Presumed on Mechanistic Targets
Current Molecular Pharmacology